Randomized Trial Of Metformin Vs Insulin - 1399 Words

1. 2. 3. 4. 5. Author, Title, Year Authors Spaulonci, Bernardes, Trindale, Zugaib, Francisco Title Randomized trial of metformin vs insulin in the management of gestational diabetes Year: 2013 Authors: Kitwitee, Limwattananon, Limwattanon, Waleekachonlert, Ratanachotpanich, Phimphilai, Nguyen, Pongchaiyakul Title Metformin for the treatment of gestational diabetes: An updated meta-analysis Year 2015 Authors: Corbould, Swinton, Radford, Campbell, McBeath, Dennis Title Fasting blood glucose predicts response to extended-release Metformin in gestation diabetes mellitus Year 2012 Authors: Gandhi, Bustani, Madhuvrata, Farrell Title Introduction of metformin for gestational diabetes mellitus in clinical practice: has it had an impact? Year†¦show more content†¦After excluding criteria that failed to meet inclusion criteria, eight studies were included in the final analysis Seventy-one women who had GDM at 24 weeks’ gestation but before 32 weeks using the Australian Diabetes in Pregnancy Society criteria. From May 2008 to April 2009, women with GDM were offered metformin as an alternative to insulin. Inclusion criteria included: diagnosis of GDM between 24-32 weeks of gestation, singleton pregnancy, no pregnancy complications and no documented intolerances from Metformin. 592 women with GDM were enrolled in the study. 299 did not receive metformin while 293 received metformin along with diet and exercise. A total of 200 pregnant women diagnosed with GDM. Group A (n=100) was treated with metformin, and group B (n=100) was treated with insulin. Independent and Dependent Variables Dependent Variable: Maternal outcome such as: frequency of preeclampsia, rate of C-section, maternal weight gain Neonatal outcome such as: 1- and 5- minute Apgar score, umbilical cord pH, macrosomnia, neonatal hypoglycemia. Independent Variable: Use of Metformin in the treatment of GDM vs insulin Dependent Variable: Maternal outcome such as: frequency of preeclampsia, rate of C-section, maternal weight gain Neonatal outcome such as: 1- and 5- minute Apgar score, umbilical cord pH, macrosomnia, neonatal hypoglycemia. Independent Variable: Use of Metformin in the treatmentShow MoreRelatedA Brief Note On Diabetes And The Treatment Of Type 1 Diabetes Mellitus921 Words   |  4 PagesReview Article Introduction: Type 1 diabetes, also known as insulin-dependent diabetes, is a chronic condition in which body produces little to no insulin due to autoimmune destruction of the beta cells of the pancreas. Patient with Type 1 diabetes are mainly treated with subcutaneous insulin injection, along with dietary and lifestyle modification. Purpose of this article is to evaluate the role of DPP-4 inhibitors in the treatment of Type 1 diabetes mellitus. DPP-4 inhibitors inhibit the degradationRead MoreContent for Glimepiride + Metformin 1461 Words   |  6 PagesContent for Glimepiride + Metformin Background: The worldwide prevalence of diabetes mellitus (DM) has increased dramatically in the past 20 years. Insulin resistance occurs early in type 2 disease. This leads to progressive beta cell failure and overt diabetes. Though monotherapy can slow down this process, it does not prevent the progression of the disease. To address, both insulin resistance and beta cell dysfunction, combination therapy is required. Clinical evidence suggests that combinationRead MoreImproving the Guidelines for Combination Therapy for Type II Diabetes Patients1975 Words   |  8 PagesHbA1C levels on lifestyle changes, Metformin is added and over a period of three months, if the patient does not reach the target A1C levels, patient can be started on two drug combinations and we have several options to do this, from sulfonylureas, TZDs ,GLP-1 Analogues, DPP-4 inhibitors and insulin. A search of literature for this combination (2) shows that there are very few clinical studies conducted with the combination of GLP 1 analogues and Insulin and in these studies it was more commonRead MoreDifferentiating Between Type 1 and 2 Diabetes Mellitus1497 Words   |  6 Pagesthe endocrine system primarily differentiated between type 1 and type 2. Type 1 diabetes occurs when the pancreas is unable to produce insulin and was previously seen in the younger generation which is no longer the case.1 Type 2 diabetes is the more prevalent of the two types and involves elevated blood sugar levels due to the insufficient production of insulin. Risk factors that make an individual higher risk for type 2 diabetes include increasing age, obesity, family history, a sedentary lifestyleRead MoreTreatment Of Gestational Diabetes Mellitus3510 Words   |  15 PagesTreatment of gestational diabetes mellitus, whether using insulin, oral diabetes medications, or another means, reduced maternal, fetal, and neonatal risks associated with the disease. When treating GDM, the goal is to bring the patient’s blood glucose levels down to the same levels as those of pregnant women without GDM. Current therapeutic targets are: fasting blood glucose ≠¤95 mg/dL, 1-hour postprandial 140 mg/dL, and 120 mg/dL for 2-hour postprandial blood glucose concentrations (HernandezRead MoreVitamin B12 And The Diabetes Prevention Program Research1313 Words   |  6 PagesBray, David S. Schade, Marinella G. Temprosa, Neil H. White, Jill P. Crandall, and the Diabetes Prevention Program Research Group OBJECTIVE The purpose of this study was to assess the risks involved in B12 deficiency because of the long-term use of Metformin in diabetes prevention. BACKGROUND Vitamin B12 (also known as Cyanocobalamin and Cobalamin) is one of eight B-vitamins. Commonly, all B-vitamins help in the conversion of carbohydrates to glucose, producing energy. Vitamin B12 main role is in maintainingRead MoreDifferences Between Glimepiride And Hypoglycemia1076 Words   |  5 PagesNon-diabetic volunteers (age 38 ±2 yrs, BMI 26 ±1kg/m2) were studied in a single-blind fashion during separate 2 day randomized protocols consisting of 2 hr hyperinsulinemic (9pmol/kg/min) euglycemic (4.9 ±0.1mmol) and hypoglycemic (2.9 ±0.1mmol/L) clamps. Individuals received biologically equivalent doses of glimepiride (4mg) or glyburide (10mg) 1 hr prior to each glucose clamp (n=11) as well as a control group of placebo studies. Glucose kinetics were calculated using D-Glucose-6-6d2. this study hasRead MoreDiabetes : The Most Common Type Of Diabetes2258 Words   |  10 Pagesglucose due to insulin resistance or deficiency. About 29.1 million people in America are reported t o have diabetes with the highest prevalence occurring in men; about 25.9% of adults 65 years and older have diabetes.1 Type 2 diabetes (T2DM) is the most common type of diabetes, often due to insulin resistance. Metformin is the treatment of choice in patients with T2DM, a second agent such as a sulfonylurea is added to metformin in patients who are not at goal or unable to tolerate metformin therapy. AccordingRead MoreDiabetes Mellitus, Burden And Trends1250 Words   |  5 PagesDiabetes Mellitus, burden and trends in diabetes-related Complications Diabetes is a serious chronic disease, which occurs when the body becomes resistant to insulin or doesn t make enough insulin (T2DM, usually in adults) or the body can’t effectively use the insulin (T1DM) (WHO definition: http://www.who.int/diabetes/en/). WHO diagnostic criteria for DM is the FPG 7.0mmol/l. This diagnostic point affect the risk of micro-vascular complications such as retinopathy, neuropathy, renal failure andRead MoreThe Effects Of Prediabetes On Growth And Pubertal Development3097 Words   |  13 Pagesno report of systematic evaluation of health outcomes related to prediabetes in children. The effects of pharmacotherapy of prediabetes on growth and pubertal development in children are unknown. Secondary intervention with pharmacotherapy with metformin is advocated for high-risk individuals but criteria for such consideration benefit of early intervention, long term cost effectiveness of such interventions and the end point of therapy remain unclear. Pharma cotherapy must be used with caution in